Baxter International (NYSE:BAX) Updates Q1 2025 Earnings Guidance

Baxter International (NYSE:BAX) updated its first quarter 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.470-0.500 for the period, compared to the consensus estimate of 0.490. The company issued revenue guidance of $3.7 billion-$3.7 billion, compared to the consensus revenue estimate of $2.6 billion. Baxter International also updated its FY 2025 guidance to 2.450-2.550 EPS.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. JPMorgan Chase & Co. lowered their target price on shares of Baxter International from $38.00 to $36.00 and set a “neutral” rating on the stock in a research note on Friday. Barclays assumed coverage on shares of Baxter International in a research report on Thursday. They issued an “overweight” rating and a $39.00 price target on the stock. StockNews.com lowered Baxter International from a “buy” rating to a “hold” rating in a report on Monday, November 11th. Stifel Nicolaus cut their target price on shares of Baxter International from $46.00 to $38.00 and set a “buy” rating for the company in a research note on Monday, November 11th. Finally, Citigroup lowered their price target on shares of Baxter International from $37.00 to $35.00 and set a “neutral” rating for the company in a research report on Wednesday, December 11th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Baxter International presently has a consensus rating of “Hold” and a consensus price target of $38.80.

Baxter International Stock Up 0.9 %

Shares of BAX traded up $0.29 during mid-day trading on Friday, hitting $33.73. 1,935,334 shares of the company traded hands, compared to its average volume of 4,766,608. Baxter International has a 1-year low of $28.33 and a 1-year high of $44.01. The business has a 50 day moving average of $30.57 and a 200 day moving average of $34.14. The company has a quick ratio of 1.09, a current ratio of 1.43 and a debt-to-equity ratio of 1.31. The company has a market capitalization of $17.22 billion, a PE ratio of 168.38, a price-to-earnings-growth ratio of 9.83 and a beta of 0.61.

Baxter International (NYSE:BAX) last issued its earnings results on Thursday, February 20th. The medical instruments supplier reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.52 by $0.06. Baxter International had a net margin of 0.77% and a return on equity of 18.30%. The business had revenue of $2.75 billion during the quarter, compared to analysts’ expectations of $2.67 billion. Equities research analysts anticipate that Baxter International will post 1.83 EPS for the current year.

Baxter International Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Friday, February 28th will be paid a dividend of $0.17 per share. The ex-dividend date is Friday, February 28th. This represents a $0.68 annualized dividend and a yield of 2.02%. Baxter International’s dividend payout ratio is currently 340.02%.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.